Sparse purine tablets
Number of views:
1000
Sparse purine tablets
English name: Mercaptopurine Tablets
Chinese Pinyin: Qiupiaoling Pian
Ingredients: The main ingredients of this product are: mercaptopurine
Chemical name: 6-purine thiol-hydrate
Indications: Suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia and acute non-lymphocytic leukemia, the blast phase of chronic myeloid leukemia.
Product serial number
Category
Tel： 0571-88966011
1
Product description
Parameters
Generic name: Mercaptopurine tablets
English name: Mercaptopurine Tablets
Chinese Pinyin: Qiupiaoling Pian
Ingredients: The main ingredients of this product are: mercaptopurine
Chemical name: 6-purine thiol-hydrate
Indications: Suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia and acute non-lymphocytic leukemia, the blast phase of chronic myeloid leukemia.
Keyword:
sparse
mercaptopurine
name
acute
leukemia
of
ingredients
the
tablets
indications
Previous
None
Related products
-
Generic name: Mercaptopurine tablets English name: Mercaptopurine Tablets Chinese Pinyin: Qiupiaoling Pian Ingredients: The main ingredients of this product are: mercaptopurine Chemical name: 6-purine thiol-hydrate Indications: Suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia and acute non-lymphocytic leukemia, the blast phase of chronic myeloid leukemia.Sparse purine tablets0.00Generic name: Mercaptopurine tablets English name: Mercaptopurine Tablets Chinese Pinyin: Qiupiaoling Pian Ingredients: The main ingredients of this product are: mercaptopurine Chemical name: 6-purine thiol-hydrate Indications: Suitable for choriocarcinoma, malignant hydatidiform mole, acute lymphocytic leukemia and acute non-lymphocytic leukemia, the blast phase of chronic myeloid leukemia. -
Cetirizine hydrochloride tablets were first developed and marketed by the Belgian UCB company in 1987. It has now been marketed in more than 100 countries or regions and was included in the 1997 European Pharmacopoeia. In 1991, UCB was approved to be sold in the Chinese market, and the clinical effect was definite. In 1995, Zhejiang Zhebei Pharmaceutical Co., Ltd. and China Normal University jointly developed a new drug, Wei Dimin, which was approved to be marketed in 2000. It has been clinically proven to be effective and easy to use.Cetirizine hydrochloride0.00Cetirizine hydrochloride tablets were first developed and marketed by the Belgian UCB company in 1987. It has now been marketed in more than 100 countries or regions and was included in the 1997 European Pharmacopoeia. In 1991, UCB was approved to be sold in the Chinese market, and the clinical effect was definite. In 1995, Zhejiang Zhebei Pharmaceutical Co., Ltd. and China Normal University jointly developed a new drug, Wei Dimin, which was approved to be marketed in 2000. It has been clinically proven to be effective and easy to use. -
Indications: Adjuvant therapy for myocardial ischemia.Fructose Sodium Diphosphate Oral Solution0.00Indications: Adjuvant therapy for myocardial ischemia. -
Generic name: Sodium fructose diphosphate Generic name: Sodium fructose diphosphate Chemical name: Fructose-1,6-bisphosphate trisodium salt octahydrate Pinyin name: Zhusheyong Guotang’erlinsuann English name: Sodium Fructose Diphosphate For Injection Molecular formula: C6H11Na3012P2•8H20 Molecular weight: 550.17 Indications: Adjuvant treatment of myocardial ischemia, shock, hypoxia, tissue damageSodium Fructose Diphosphate For Injection0.00Generic name: Sodium fructose diphosphate Generic name: Sodium fructose diphosphate Chemical name: Fructose-1,6-bisphosphate trisodium salt octahydrate Pinyin name: Zhusheyong Guotang’erlinsuann English name: Sodium Fructose Diphosphate For Injection Molecular formula: C6H11Na3012P2•8H20 Molecular weight: 550.17 Indications: Adjuvant treatment of myocardial ischemia, shock, hypoxia, tissue damage -
Generic name: Inosine oral solution English name: Inosine Oral Solution Chinese Pinyin: Jigan Koufurongye Ingredients: Each bottle of this product contains 0.2g of inosine Excipients: sucrose, flavor, sodium sulfite Indications: For adjuvant treatment of acute and chronic hepatitis Pharmacological effects: Inosine participates in cell energy metabolism and protein synthesis in the body, improves the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver.Gump oral liquid0.00Generic name: Inosine oral solution English name: Inosine Oral Solution Chinese Pinyin: Jigan Koufurongye Ingredients: Each bottle of this product contains 0.2g of inosine Excipients: sucrose, flavor, sodium sulfite Indications: For adjuvant treatment of acute and chronic hepatitis Pharmacological effects: Inosine participates in cell energy metabolism and protein synthesis in the body, improves the activity of related metabolic enzymes, improves liver function, and promotes the recovery of damaged liver. -
Generic name: Acyclovir tablets English name: Aciclovir Tablets Chinese Pinyin: Axiluowei Pian Chemical name: 9-(2-hydroxyethoxymethyl)guanineAcyclovir Tablets0.00Generic name: Acyclovir tablets English name: Aciclovir Tablets Chinese Pinyin: Axiluowei Pian Chemical name: 9-(2-hydroxyethoxymethyl)guanine -
1. Suitable for viral pneumonia, bronchitis, and skin herpes virus infections caused by respiratory syncytial virus. 2. Interferon α Combined use to treat adult chronic hepatitis C.Ribavirin Tablets0.001. Suitable for viral pneumonia, bronchitis, and skin herpes virus infections caused by respiratory syncytial virus. 2. Interferon α Combined use to treat adult chronic hepatitis C. -
API description: It can be made into acyclovir injection, acyclovir dispersible tablets, acyclovir cream, acyclovir eye drops, acyclovir gel, acyclovir oral solution, acyclovir Cyclovir tablets.Aciclovir0.00API description: It can be made into acyclovir injection, acyclovir dispersible tablets, acyclovir cream, acyclovir eye drops, acyclovir gel, acyclovir oral solution, acyclovir Cyclovir tablets.
©2021 Zhejiang Zhebei Pharmaceutical Co., Ltd. All rights reserved
